Primary gastrointestinal stromal tumor of the liver: a case report

被引:0
作者
Pham, Anh Tuan [1 ]
Pham, Anh The [2 ]
Truong, Cuong Manh [2 ]
Nguyen, Thang Huu [1 ]
Trinh, Phuong Huy [2 ]
机构
[1] Vietnam Natl Canc Hosp, Dept Optimal Clin Care, 30 Cau Buou, Hanoi, Vietnam
[2] Vietnam Natl Canc Hosp, Dept of Hepatobiliary & Pancreat Surg, 30 Cau Buou, Hanoi 12500, Vietnam
关键词
adjuvant therapy; gastrointestinal stromal tumor; hepatectomy; DIFFERENTIAL-DIAGNOSIS; FEATURES; GIST; KIT; MUTATIONS; PET/CT; CD117; DOG1;
D O I
10.1097/MS9.0000000000002228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and importance:Primary gastrointestinal stromal tumors of the liver are exceedingly rare entities, presenting diagnostic and therapeutic challenges. The authors present a case of a 64-year-old male with a primary gastrointestinal stromal tumor (GIST) of the liver, emphasizing the importance of comprehensive diagnostic evaluation and multidisciplinary management in such uncommon cases.Case presentation:The patient presented with persistent hypochondriac pain, leading to the discovery of a hepatic mass. Diagnostic work-ups, including imaging studies and biopsy, confirmed the diagnosis of primary GIST in the liver. Following thorough multidisciplinary consultation, the patient underwent right anterior segmentectomy of the liver, performed by our experienced surgeon. Postoperative pathology confirmed the diagnosis of GIST, and the patient was advised to use adjuvant imatinib.Clinical discussion:Primary GISTs of the liver pose diagnostic challenges due to their rarity and varied clinical presentations. Imaging modalities, immunohistochemistry, and molecular genotyping are crucial in accurate diagnosis and treatment planning. Surgical resection remains the cornerstone of treatment for localized GISTs, with adjuvant therapy considered based on recurrence risk factors and molecular characteristics.Conclusion:This case highlights the need for multidisciplinary consultation in managing primary GISTs of the liver. Accurate diagnosis, surgical expertise, and personalized adjuvant therapy are crucial for better patient outcomes. Further research is necessary to enhance our understanding of prognostic factors and treatment strategies for these rare tumors.
引用
收藏
页码:4284 / 4290
页数:7
相关论文
共 34 条
[1]  
Beltran Marcelo A, 2007, Int J Surg, V5, P183, DOI 10.1016/j.ijsu.2006.05.006
[2]  
Bhoy Tejal, 2014, Trop Gastroenterol, V35, P252
[3]   Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Casali, P. G. ;
Blay, J. Y. ;
Abecassis, N. ;
Bajpai, J. ;
Bauer, S. ;
Biagini, R. ;
Bielack, S. ;
Bonvalot, S. ;
Boukovinas, I ;
Bovee, J. V. M. G. ;
Boye, K. ;
Brodowicz, T. ;
Buonadonna, A. ;
De Alava, E. ;
Dei Tos, A. P. ;
Del Muro, X. G. ;
Dufresne, A. ;
Eriksson, M. ;
Fedenko, A. ;
Ferraresi, V ;
Ferrari, A. ;
Frezza, A. M. ;
Gasperoni, S. ;
Gelderblom, H. ;
Gouin, F. ;
Grignani, G. ;
Haas, R. ;
Hassan, A. B. ;
Hindi, N. ;
Hohenberger, P. ;
Joensuu, H. ;
Jones, R. L. ;
Jungels, C. ;
Jutte, P. ;
Kasper, B. ;
Kawai, A. ;
Kopeckova, K. ;
Krakorova, D. A. ;
Le Cesne, A. ;
Le Grange, F. ;
Legius, E. ;
Leithner, A. ;
Lopez-Pousa, A. ;
Martin-Broto, J. ;
Merimsky, O. ;
Messiou, C. ;
Miah, A. B. ;
Mir, O. ;
Montemurro, M. ;
Morosi, C. .
ANNALS OF ONCOLOGY, 2022, 33 (01) :20-33
[4]   Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2002, 10 (02) :81-89
[5]   Torricelli-Bernoulli sign in an ulcerating gastric leiomyosarcoma [J].
Fortman, BJ .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 173 (01) :199-200
[6]   PDGFRA activating mutations in gastrointestinal stromal tumors [J].
Heinrich, MC ;
Corless, CL ;
Duensing, A ;
McGreevey, L ;
Chen, CJ ;
Joseph, N ;
Singer, S ;
Griffith, DJ ;
Haley, A ;
Town, A ;
Demetri, GD ;
Fletcher, CDM ;
Fletcher, JA .
SCIENCE, 2003, 299 (5607) :708-710
[7]   Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors [J].
Hirota, S ;
Ohashi, A ;
Nishida, T ;
Isozaki, K ;
Kinoshita, K ;
Shinomura, Y ;
Kitamura, Y .
GASTROENTEROLOGY, 2003, 125 (03) :660-667
[8]  
Hu XJ, 2003, ARCH PATHOL LAB MED, V127, P1606
[9]   Pediatric KIT-wild-type and platelet-derived growth factor receptor α-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors [J].
Janeway, Katherine A. ;
Liegl, Bernadette ;
Harlow, Amy ;
Le, Claudia ;
Perez-Atayde, Antonio ;
Kozakewich, Harry ;
Corless, Christopher L. ;
Heinrich, Nflchael C. ;
Fletcher, Jonathan A. .
CANCER RESEARCH, 2007, 67 (19) :9084-9088
[10]   Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial [J].
Jones, Robin L. ;
Serrano, Cesar ;
von Mehren, Margaret ;
George, Suzanne ;
Heinrich, Michael C. ;
Kang, Yoon-Koo ;
Schoffski, Patrick ;
Cassier, Philippe A. ;
Mir, Olivier ;
Chawla, Sant P. ;
Eskens, Ferry A. L. M. ;
Rutkowski, Piotr ;
Tap, William D. ;
Zhou, Teresa ;
Roche, Maria ;
Bauer, Sebastian .
EUROPEAN JOURNAL OF CANCER, 2021, 145 :132-142